Cargando…
HDAC/IKK inhibition therapies in solid tumors
Autores principales: | Vancurova, Ivana, Gatla, Himavanth R., Vancura, Ales |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470948/ https://www.ncbi.nlm.nih.gov/pubmed/28504965 http://dx.doi.org/10.18632/oncotarget.17512 |
Ejemplares similares
-
IKK inhibition increases bortezomib effectiveness in ovarian cancer
por: Singha, Bipradeb, et al.
Publicado: (2015) -
Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
por: Uddin, Mohammad M., et al.
Publicado: (2018) -
Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
por: Gatla, Himavanth R., et al.
Publicado: (2017) -
Transcriptional Regulation of Chemokine Expression in Ovarian Cancer
por: Singha, Bipradeb, et al.
Publicado: (2015) -
Metformin induces protein acetylation in cancer cells
por: Vancura, Ales, et al.
Publicado: (2017)